These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1925514)

  • 41. [Long-term central venous lines and their complications].
    Teichgräber UK; Gebauer B; Benter T; Wagner J
    Rofo; 2004 Jul; 176(7):944-52. PubMed ID: 15237335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients.
    Biffi R; Pozzi S; Agazzi A; Pace U; Floridi A; Cenciarelli S; Peveri V; Cocquio A; Andreoni B; Martinelli G
    Ann Oncol; 2004 Feb; 15(2):296-300. PubMed ID: 14760125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Subcutaneous venous reservoirs: comparative study of their efficacy in patients with AIDS versus oncology and hematology patients].
    Moral A; Targarona EM; Mallolas J; Martínez J; Pros I; Valverde M; Palombo H; Trias M
    Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):190-4. PubMed ID: 8512970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tesio-Caths provide effective and safe long-term vascular access.
    Duncan ND; Singh S; Cairns TD; Clark M; El-Tayar A; Griffith M; Hakim N; Hamady M; McLean AG; Papalois V; Palmer A; Taube D
    Nephrol Dial Transplant; 2004 Nov; 19(11):2816-22. PubMed ID: 15340094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system.
    Strum S; McDermed J; Korn A; Joseph C
    J Clin Oncol; 1986 Apr; 4(4):596-603. PubMed ID: 3958769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
    Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
    J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Complications of central venous access devices: outcome analysis of 2359 implantations].
    Stein M; Wagner RH
    Dtsch Med Wochenschr; 2005 May; 130(18):1129-32. PubMed ID: 15856394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
    Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
    Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage?
    Azaïs H; Bresson L; Bassil A; Katdare N; Merlot B; Houpeau JL; El Bedoui S; Meurant JP; Tresch E; Narducci F
    J Vasc Access; 2015; 16(1):31-7. PubMed ID: 25362986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Port-A-Cath and Per-Q-Cath.
    Hammond LJ
    J Pediatr Health Care; 1991; 5(1):31-3. PubMed ID: 1990114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mystery of the occluded port that allowed blood withdrawal: is it safe to use standard needles to access ports? A case report and literature review.
    Cataldo R; Costa F; Vitiello M; Brescia F; Proscia P; Falco C; Carassiti M
    J Surg Oncol; 2014 Apr; 109(5):500-3. PubMed ID: 24310214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
    Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
    Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extravasation of infusate via implanted ports: two case studies.
    Viale PH; Yamamoto DS; Geyton JE
    Clin J Oncol Nurs; 1999 Oct; 3(4):145-51. PubMed ID: 10703320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug extravasation and the Port-a-Cath system.
    Strum SB; McDermed JE
    Ann Intern Med; 1985 Sep; 103(3):472-3. PubMed ID: 4026096
    [No Abstract]   [Full Text] [Related]  

  • 56. Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation.
    Garajová I; Nepoti G; Paragona M; Brandi G; Biasco G
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):125-32. PubMed ID: 22966988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome of tunneled hemodialysis catheters placed by radiologists.
    Lund GB; Trerotola SO; Scheel PF; Savader SJ; Mitchell SE; Venbrux AC; Osterman FA
    Radiology; 1996 Feb; 198(2):467-72. PubMed ID: 8596851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
    Mayo DJ; Pearson DC
    Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
    Weber M; Meyer F; Halloul Z
    Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Complications at the implantation site].
    Desruennes E; Gaudry B; Rossard S; Rodriguez C
    Soins; 1999 Nov; (640 Suppl):16-20. PubMed ID: 10948968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.